Policy expert helped negotiate major victories for the patient community on 21st Century Cures Act, PDUFA, FDA’s Patient-Focused Drug Development initiative
WASHINGTON (July 26, 2017)
The Personalized Medicine Coalition (PMC) is pleased to announce that Cynthia Bens, a leading policy expert who helped negotiate major victories for the patient community on policies that include the 21st Century Cures Act, the Prescription Drug User Fee Act (PDUFA) and FDA’s Patient-Focused Drug Development (PFDD) initiative during more than a decade with the Alliance for Aging Research, will join PMC’s team on August 21 as vice president, public policy.
As the Alliance’s vice president, public policy, Bens, who testified before Congress in April on the significance and design of PDUFA VI, worked to help secure funding for hiring and retention at FDA as part of PDUFA and the 21st Century Cures Act. As the leader of the organization’s federal policy work, she also spearheaded a successful effort by the Aging in Motion (AIM) coalition to catalyze a PFDD meeting on sarcopenia at FDA.
"Cynthia Bens is a pure play policy expert with an unrivaled ability to organize diverse groups of stakeholders around issues that matter,” said PMC Board member Brian Munroe, who currently serves as senior vice president, government affairs, at Endo Pharmaceuticals. "She is exceptionally qualified to lead the Coalition’s advocacy efforts.”
Bens is also a long-time advocate for personalized medicine. The Alliance joined PMC in 2007 under her direction, and Bens has worked with the Coalition to help create a friendlier landscape for the field ever since. She has also tackled the topic as the director of the Accelerate Cure/Treatments for Alzheimer’s Disease coalition and as part of the Foundation for the National Institutes of Health’s Biomarker Consortium Sarcopenia 2 Project Team.
"I believe personalized medicine represents the future of health care,” Bens explains. "Now is the time to align our public policies with the principles of individual variation, and I am excited to work with the Coalition to advance its agenda.”
Prior to her role as vice president, Bens, who has more than 15 years of experience in federal government relations, served as the Alliance’s public policy director. She came to the Alliance after four years with the Loeffler Group, a bipartisan government affairs firm, and has also worked as a staff assistant on Capitol Hill.
"Given the breadth and depth of her experience in federal government relations and her demonstrated ability to lead multi-stakeholder coalitions, Cynthia is well-positioned to work with PMC’s members as they seek to put in place policies that will unlock a new era in health care,” said PMC President Edward Abrahams. "We look forward to working with her.”
Christopher J. Wells
About the Personalized Medicine Coalition:
The Personalized Medicine Coalition, representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system. For more information about PMC, please visit www.personalizedmedicinecoalition.org.